Lotus Clinical Research secures private equity backing
Lotus Clinical Research (Lotus) of Pasadena, California, has entered into a private equity partnership with DFW Capital Partners and has added Jeffrey Kinell and Kurt Brykman to its board of directors in conjunction with the investment. Kinell was previously the CEO of Bracket Global, a leader in the clinical trials technology space,

